Applying Innovative Technologies to Generic Medication | Yaral Pharma
YARAL Pharma, Inc., which launched in 2022, is the U.S. generics subsidiary of IBSA, a long-standing, fully integrated, multinational pharmaceutical company headquartered in Lugano, Switzerland. Yaral is committed to providing high-quality products across a range of therapeutic areas, ensuring continuity of supply, and offering affordable authorized generics and complex generic medicines. In this episode, we focus on IBSA's innovative patch and Softgel technologies and how YARAL Pharma leverages this technology, aiming to reshape the landscape of patient care and pharmaceutical excellence.
You May Also Like

Asmongold TV
Asmongold TV
Newshour
BBC World Service

Siste nytt fra VG
VG

24/7 News: The Latest
iHeartPodcasts and TTWN

Unofficial QuickBooks Accountants Podcast
Alicia Katz Pollock, MAT

ABC News Daily
ABC Australia

Las noticias de la SER
SER Podcast

Actu Crypto - L'actualité des cryptomonnaies en direct
Cryptoast

Bloomberg News Now
Bloomberg

Plus
Český rozhlas
Community discussion